TY - JOUR
T1 - Synthesis of [d-ALA2, 4′-125I-PHE3, GLU4] deltorphin and characterization of its δ opioid receptor binding properties
AU - Fang, Lei
AU - Knapp, Richard J.
AU - Matsunaga, Terry
AU - Weber, Steven J.
AU - Davis, Thomas
AU - Hruby, Victor J.
AU - Yamamura, Henry I.
N1 - Funding Information:
This research was supported by National Institute of Drug Abuse grants DA 04248 and DA 06284.
PY - 1992
Y1 - 1992
N2 - Both [d-Ala2, Glu4]Deltorphin and [d-Ala2, 4′-I-Phe3, Glu4]Deltorphin are highly selective ligands for δ, relative to μ, opioid receptors. Radiolabeled [d-Ala2, 4′-125I-Phe3, Glu4]Deltorphin ([125I]Deltorphin) was prepared with a specific activity of 2200 Ci/mmol from [d-Ala2, 4′-NH2-Phe3, Glu4]Deltorphin through a diazonium salt intermediate. The inhibition of [125I]Deltorphin binding to rat brain membranes by ligands selective for μ, δ, and κ opioid receptors is consistent with binding by the radioligand to a single site having the properties of a δ opioid receptor. The results of these studies are in good agreement with those obtained by structurally different δ opioid receptor ligands. The similarity between the δ receptor site labeled by [125I]Deltorphin and those labeled by other δ receptor agonists, in contrast to differences seen by in vivo studies of their analgesic effects, is discussed.
AB - Both [d-Ala2, Glu4]Deltorphin and [d-Ala2, 4′-I-Phe3, Glu4]Deltorphin are highly selective ligands for δ, relative to μ, opioid receptors. Radiolabeled [d-Ala2, 4′-125I-Phe3, Glu4]Deltorphin ([125I]Deltorphin) was prepared with a specific activity of 2200 Ci/mmol from [d-Ala2, 4′-NH2-Phe3, Glu4]Deltorphin through a diazonium salt intermediate. The inhibition of [125I]Deltorphin binding to rat brain membranes by ligands selective for μ, δ, and κ opioid receptors is consistent with binding by the radioligand to a single site having the properties of a δ opioid receptor. The results of these studies are in good agreement with those obtained by structurally different δ opioid receptor ligands. The similarity between the δ receptor site labeled by [125I]Deltorphin and those labeled by other δ receptor agonists, in contrast to differences seen by in vivo studies of their analgesic effects, is discussed.
UR - http://www.scopus.com/inward/record.url?scp=0026618677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026618677&partnerID=8YFLogxK
U2 - 10.1016/0024-3205(92)90628-3
DO - 10.1016/0024-3205(92)90628-3
M3 - Article
C2 - 1331636
AN - SCOPUS:0026618677
SN - 0024-3205
VL - 51
SP - PL189-PL193
JO - Life Sciences
JF - Life Sciences
IS - 20
ER -